| Wall Street Journal | - |
In
a statement, Chimerix Inc. said it has provided its experimental
antiviral for potential use in patients with Ebola, following emergency
requests by treating physicians; it didn't identify any patients
receiving the drug.
Drug Maker Provides Experimental Drug To Treat Texas Ebola Patient
Thomas Eric Duncan (File)
The drug company, Chimerix Inc., said earlier that doctors it did not identify had received permission from the U.S. Food and Drug Administration to use the drug, brincidofovir.
The oral antiviral drug is currently in late-stage testing for use against several common viruses, including one that infects patients undergoing bone marrow transplants.
Laboratory tests suggested it might also fight Ebola.
The FDA grants emergency access to unapproved drugs on a case-by-case basis, usually when a patient faces a life-threatening condition for which there are no alternatives.
The agency has not approved any drugs or vaccines to safely and effectively treat Ebola.
Thomas Eric Duncan, 42, was diagnosed with Ebola in Dallas last Tuesday after recently arriving from Liberia.
His condition was downgraded to critical over the weekend.
The hospital described his condition Monday as stable.
end quote from:
No comments:
Post a Comment